Seroquel News
RPT BROKERWATCH AstraZeneca target price cut to 2100 pence from ... - Euro2day
In a note to clients this morning, HSBC said its base case scenario for valuation is six month generic competition for Seroquel and Nexium in the US in ...
AstraZeneca Submits Seroquel XR™ in Europe for the Treatment of ... - PR-USA.net (press release)
AstraZeneca also announced it has submitted a further application in the EU for SEROQUEL® (quetiapine fumarate immediate release, IR) for the treatment of ...
AstraZeneca Seeks Additional Indication for Seroquel XR - FDA news (subscription)
AstraZeneca has submitted a supplemental new drug application to the FDA for once-daily Seroquel extended-release (XR) tablets to treat major depressive ...
AstraZeneca submits Seroquel XR to FDA for major depressive ... - CNNMoney.com
Adding new indications to Seroquel XR is seen as a crucial way for the company to bring in sorely needed additional revenues in the coming few years as ...
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of ... - PR Newswire (press release)
(3) AstraZeneca has investigated the use of SEROQUEL XR, an atypical antipsychotic, in the treatment of MDD, aiming to develop another potential treatment ...
AstraZeneca seeks more US approvals for Seroquel XR - Reuters
L: Quote, Profile, Research) said on Friday it had submitted a once-daily version of its blockbuster Seroquel medicine for approval by US regulators to ...
AstraZeneca submits Seroquel XR to FDA for major depressive ... - CNNMoney.com
Adding new indications to Seroquel XR is seen as a crucial way for the company to bring in sorely needed additional revenues in the coming few years as ...
AstraZeneca submits Seroquel XR in USA for depression - Pharma Times (subscription)
AstraZeneca is looking to get approval for the extended-release version of its blockbuster antipsychotic Seroquel from US regulators as a treatment for ...
FTSE 100 risers: Astra hit by JPM price cut - ShareCast
It added that it saw this declining to 21.4% in 2013 as the company feels the full impact of the loss of the patent for the anti-psychotic drug Seroquel. ...
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of ... - CNNMoney.com (press release)
(3) AstraZeneca has investigated the use of SEROQUEL XR, an atypical antipsychotic, in the treatment of MDD, aiming to develop another potential treatment ...
Seroquel RSS Feed